HLB PANAGENE Co., LTD. Logo

HLB PANAGENE Co., LTD.

Specializes in PNA-based molecular diagnostics for oncology and infectious diseases.

046210 | KO

Overview

Corporate Details

ISIN(s):
KR7046210001
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노10로 54, 대전광역시

Description

HLB PANAGENE is a molecular diagnostics company specializing in proprietary Peptide Nucleic Acid (PNA) technology. The company develops, manufactures, and supplies a range of in vitro diagnostic (IVD) products for personalized medicine, with a focus on oncology and infectious diseases. Its portfolio includes diagnostic solutions for various cancers, such as lung, colorectal, and thyroid, by detecting key genetic mutations. The company also offers real-time PCR-based kits for infectious agents like HPV and STIs. Leveraging its PNA platform for high accuracy and rapid analysis, HLB PANAGENE provides PNA materials and diagnostic kits to a global market. Through its subsidiary, the company is expanding its capabilities into immunodiagnostics and point-of-care testing.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-26 00:00
주식등의대량보유상황보고서(일반)
Korean 121.6 KB
2025-08-26 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-08-26 00:00
주식등의대량보유상황보고서(일반)
Korean 101.6 KB
2025-08-20 00:00
주권관련사채권의취득결정
Korean 38.2 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.3 MB
2025-07-18 00:00
[기재정정]사업보고서 (2024.12)
Korean 1.8 MB
2025-07-18 00:00
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 15.2 KB
2025-07-18 00:00
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 14.3 KB
2025-06-05 00:00
전환청구권행사
Korean 11.3 KB
2025-05-19 00:00
주식등의대량보유상황보고서(일반)
Korean 230.1 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.3 MB
2025-05-14 00:00
전환청구권행사
Korean 11.3 KB
2025-04-22 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-04-22 00:00
주식등의대량보유상황보고서(일반)
Korean 100.3 KB
2025-04-18 00:00
전환가액의조정
Korean 16.4 KB

Automate Your Workflow. Get a real-time feed of all HLB PANAGENE Co., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB PANAGENE Co., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB PANAGENE Co., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.